PEPT Among Its Peers
End-of-day Nov 19, 2026 · 1 ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.1% | −5.0% | +1.2% | — | — | — | — | — | — | +5.1% |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$135 of every $1,000 in PEPT is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 13.52% | $1,351.72 | 315 | $436K |
| 2 | ASNDAscendis Pharma A/S | Healthcare | 11.46% | $1,145.98 | 1,366 | $369K |
| 3 | NVONovo Nordisk A/S | Healthcare | 9.93% | $993.12 | 8,116 | $320K |
| 4 | PODDInsulet | Healthcare | 7.64% | $763.69 | 1,758 | $246K |
| 5 | RYTMRhythm Pharmaceuticals | Healthcare | 6.23% | $622.85 | 1,686 | $201K |
| 6 | PTGXProtagonist Therapeutics | Healthcare | 6.16% | $615.61 | 1,560 | $198K |
| 7 | SANSanofi | Financial Services | 5.91% | $591.47 | 2,015 | $191K |
| 8 | DARDarling Ingredients | Consumer Defensive | 3.95% | $394.68 | 2,449 | $127K |
| 9 | VKTXViking Therapeutics | Healthcare | 3.63% | $363.28 | 4,473 | $117K |
| 10 | —Bachem | — | 3.59% | $358.70 | 1,228 | $116K |
| 11 | —Ipsen | — | 2.98% | $298.45 | 538 | $96K |
| 12 | PBLSParabilis Medicines | Healthcare | 2.71% | $270.89 | 3,066 | $87K |
| 13 | ZEALZealand Pharma A/S | — | 2.52% | $252.07 | 2,497 | $81K |
| 14 | AUPHAurinia Pharmaceuticals | Healthcare | 2.19% | $219.37 | 4,672 | $71K |
| 15 | MBXMBX Biosciences | Healthcare | 2.00% | $200.26 | 1,208 | $65K |
PEPT has no close peers in our data yet: […]
Not enough history yet: PEPT needs a year of prices.
PEPT does not pay a distribution.
Official documents are being connected from SEC EDGAR: […]. Read the issuer’s prospectus before investing.
Estimated yearly cost excludes trading costs and assumes constant assets.
No payouts on record: […]
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 13.52% |
| 2 | ASND | Ascendis Pharma A/S | 11.46% |
| 3 | NVO | Novo Nordisk A/S | 9.93% |
| 4 | PODD | Insulet | 7.64% |
| 5 | RYTM | Rhythm Pharmaceuticals | 6.23% |
| 6 | PTGX | Protagonist Therapeutics | 6.16% |
| 7 | SAN | Sanofi | 5.91% |
| 8 | DAR | Darling Ingredients | 3.95% |
| 9 | VKTX | Viking Therapeutics | 3.63% |
| 10 | PBLS | Parabilis Medicines | 2.71% |